Cannabigerol and cannabidiol differ in their ability to affect the AhR/CYP1A pathway in vitro.

RHO Phyto Transdermal CBG Gel (cannabidiol/cannabigerol) - Avicanna

IrniCann (cannabidiol/cannabigerol) - Argent BioPharma

http://www.ncbi.nlm.nih.gov/pubmed/42134486

Alena Rysava; Barbora Papouskova; Bohumil Zalesak; Jakub Havlasek; Jan Storch; Jan Vacek; Jiri Vrba; Katerina Dostalova; Veronika Zapletalová

May 18, 2026